pet

  1. Nightsong

    Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms, 2026, Liu et al

    Abstract: Background Dopaminergic neurons are vulnerable to injury from gliosis and have high density of ACE2 receptors, but the integrity of dopaminergic neurons has not been investigated in long COVID. This study examined whether vesicular monoamine transporter 2 (VMAT2) binding, index of...
  2. SNT Gatchaman

    Varying Levels of Inflammatory Activity in Brain and Body of Patients with Persistent Fatigue and Difficulty Concentrating After COVID…, 2025, Visser+

    Varying Levels of Inflammatory Activity in Brain and Body of Patients with Persistent Fatigue and Difficulty Concentrating After COVID-19: A TSPO PET Study A significant number of patients report persistent fatigue and difficulty concentrating after infection with severe acute respiratory...
  3. Nightsong

    Glial activation among individuals with Neurological [PASC]: A Brain Fog Positron Emission Tomography Study of [18F]-FEPPA, 2025, Clouston+

    Abstract Background: This study examined the regional distribution of glial activation in essential workers with neurological post-acute sequelae of coronavirus disease 2019 (COVID-19) infections (N-PASC). Methods: We injected ≤185 MBq of [18F]-FEPPA as an intravenous bolus and...
  4. SNT Gatchaman

    Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms, 2024, Martini et al.

    Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms Martini, Anna Lisa; Carli, Giulia; Caminiti, Silvia Paola; Kiferle, Lorenzo; Leo, Andrea; Perani, Daniela; Sestini, Stelvio PURPOSE Our study examines brain metabolic connectivity in SARS-CoV-2...
  5. SNT Gatchaman

    Frontal-striatal glucose metabolism and fatigue in patients with multiple sclerosis, long COVID, and COVID-19 recovered controls, 2024, Rudroff+

    Frontal-striatal glucose metabolism and fatigue in patients with multiple sclerosis, long COVID, and COVID-19 recovered controls Rudroff, Thorsten This study compared brain glucose metabolism using FDG-PET in the caudate nucleus, putamen, globus pallidus, thalamus, and dorsolateral prefrontal...
  6. SNT Gatchaman

    Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up FDG-PET study, 2024, Horowitz+

    Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up 18FFDG-PET study Horowitz, Tatiana; Dudouet, Pierre; Campion, Jacques-Yves; Kaphan, Elsa; Radulesco, Thomas; Gonzalez, Sandra; Cammilleri, Serge; Ménard, Amélie; Guedj, Eric...
  7. D

    Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses 2008 (Claims Objective Proof of Placebo)

    Full article available: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482600
  8. Cheshire

    Brain 18F-FDG PET imaging in outpatients with post-COV-19 conditions: findings and associations with clinical characteristics, 2022, Goehringer et al

    Abstract Background Brain 18F-FDG PET imaging has the potential to provide an objective assessment of brain involvement in post-COVID-19 conditions but previous studies of heterogeneous patient series yield inconsistent results. The current study aimed to investigate brain 18F-FDG PET findings...
Back
Top Bottom